Allander, L.; Vickberg, K.; Lagerbäck, P.; Sandegren, L.; Tängdén, T.
Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae. Antibiotics 2022, 11, 1646.
https://doi.org/10.3390/antibiotics11111646
AMA Style
Allander L, Vickberg K, Lagerbäck P, Sandegren L, Tängdén T.
Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae. Antibiotics. 2022; 11(11):1646.
https://doi.org/10.3390/antibiotics11111646
Chicago/Turabian Style
Allander, Lisa, Karin Vickberg, Pernilla Lagerbäck, Linus Sandegren, and Thomas Tängdén.
2022. "Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae" Antibiotics 11, no. 11: 1646.
https://doi.org/10.3390/antibiotics11111646
APA Style
Allander, L., Vickberg, K., Lagerbäck, P., Sandegren, L., & Tängdén, T.
(2022). Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae. Antibiotics, 11(11), 1646.
https://doi.org/10.3390/antibiotics11111646